Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromata Read more about Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromata
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202). Read more about Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. Read more about Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. Read more about Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort.
Evaluation of treatment benefit in Journal of Clinical Oncology. Read more about Evaluation of treatment benefit in Journal of Clinical Oncology.
Removing the unknown from the carcinoma of unknown primary. Read more about Removing the unknown from the carcinoma of unknown primary.
Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst. Read more about Primary hepatic lymphoma presenting as an isolated solitary hepatic cyst.
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. Read more about High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
